Search Browse Earnings

BIOCRYST PHARMACEUTICALS INC — SlamSEC

BIOCRYST PHARMACEUTICALS INC

Nasdaq:BCRX

Biological Products, (No Diagnostic Substances)·DURHAM, NC

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$48.3M

+254.6% YoY

FY 2017

Adj. EBITDA

-$102.1M

-211.5% margin

FY 2025

Net Income

-$226.5M

-469.4% margin

FY 2025

EPS (Diluted)

-$1.18

FY 2025

Stock Price

$8.48

-0.2%

2026-03-06

52W Range

$6.00 – $11.31

P/E Ratio

-7.2x

Market Cap

$2.1B

Cash

$110.6M

FY 2025

Total Debt

$344.9M

FY 2025

Net Debt

$234.2M

FY 2025

Enterprise Value

$2.4B

Debt / EBITDA

-2.3x

FY 2017

EV / EBITDA

-23.1x

Employees

—

CEO

Stonehouse Jon P